OSI Systems designs and manufactures specialized electronic systems for security and inspection, optoelectronics and manufacturing, and healthcare applications. Its fiscal first quarter, which ended September 30, 2026, sets the tone for fiscal 2027 after a fiscal 2026 that delivered record revenue of $1.79 billion yet faced Middle East delivery delays. Bookings, backlog, and cash generation serve as key indicators of demand visibility. With government security programs and recurring service revenue at the core of the growth narrative, this quarter provides an early check on whether those drivers remain on track. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
OSI Systems posted record first-quarter net revenues of $403.5 million, up 5% from $384.6 million a year earlier and ahead of the consensus estimate of roughly $396 million. Product revenue grew 5% to about $290 million, while service revenue grew 4% to about $114 million. By segment, Optoelectronics and Manufacturing grew 9% (16% to external customers), Security grew 4%, and Healthcare declined 14% on lower patient-monitoring sales.
On the bottom line, adjusted (non-GAAP) diluted EPS rose 17% to $1.66, a first-quarter record and slightly above the consensus of about $1.64. GAAP diluted EPS increased 28% to $1.51 from $1.18 a year earlier. Gross margin was 30.7%, down from 32.0%, and adjusted operating margin was 9.5% versus 10.3% in the prior-year period.
Bookings drove a 1.4 book-to-bill ratio, lifting backlog to a record $2.1 billion. Operating cash flow more than doubled to $37 million. The company reaffirmed fiscal 2027 revenue guidance of $1.875 billion to $1.930 billion and raised non-GAAP EPS guidance to $11.28–$11.64, largely reflecting the benefit of share repurchases.
Heading into the report, OSI Systems shares had been under pressure, down roughly 6% over the prior three months and about 15% over the trailing 12 months. The revenue and adjusted EPS beats, combined with an upward revision to full-year EPS guidance, created a constructive backdrop. Still, the earnings beat was modest in scale, and softer gross and adjusted operating margins along with continued Healthcare weakness gave investors reasons to stay measured. The record backlog and strong cash generation stood out as the clearest positives, supporting confidence in second-half-weighted revenue growth for fiscal 2027.
OSI Systems reaffirmed fiscal 2027 revenue guidance of $1.875 billion to $1.930 billion, with growth expected to be weighted toward the second half. Management also raised non-GAAP EPS guidance to $11.28–$11.64, a range reflecting the favorable impact of share repurchases completed during the quarter. From what I see, several items deserve attention in coming quarters. The pace at which the record $2.1 billion backlog converts to revenue will be critical, especially given the second-half delivery expectations. The Mexico program transition remains a near-term headwind concentrated in the first half. Margin trends warrant monitoring as well, since both gross margin and adjusted operating margin contracted year over year. Improvements in Healthcare and a better Security revenue mix would aid recovery. Capital allocation, including continued share repurchases, may continue to support per-share results.
When reviewing results like these, I often turn to Tickeron’s AI Screener to quickly compare setups across the security, technology, and healthcare sectors. The tool helps surface comparable names based on technical patterns, fundamentals, and performance metrics, which adds useful context without replacing the core analysis of bookings, margins, and guidance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Be on the lookout for a price bounce soon.
Following a +5.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSIS advanced for three days, in 220 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 138 of 225 cases where OSIS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for OSIS moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 27 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSIS as a result. In 46 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for OSIS turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 27 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
OSIS moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OSIS crossed bearishly below the 50-day moving average on November 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSIS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
OSIS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.758) is normal, around the industry mean (3.856). P/E Ratio (21.046) is within average values for comparable stocks, (6.228). Projected Growth (PEG Ratio) (1.427) is also within normal values, averaging (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (1.952) is also within normal values, averaging (4.422).
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. OSIS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of specialized electronic systems and components for critical applications
Industry ElectronicComponents